Kidney cancer drug safety checked in patients with poor kidney function
NCT ID NCT07117409
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 29 times
Summary
This study aimed to compare side effects of the drug nivolumab in people with metastatic kidney cancer who also have different levels of kidney function. Researchers planned to review medical records of 81 patients treated between 2017 and 2018. The study was stopped early, so results may be limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, Italy
Conditions
Explore the condition pages connected to this study.